Masimo Corp Files Definitive Additional Materials

TL;DR

MASI filed more proxy docs, no fee. Shareholders get updated info.

AI Summary

Masimo Corporation filed definitive additional materials on August 15, 2024, regarding its proxy statement. The filing, designated as DEFA14A, indicates no fee was required for this submission. The company, headquartered in Irvine, CA, operates in the electromedical apparatus industry.

Why It Matters

This filing provides updated or supplementary information to shareholders concerning matters to be voted on at a company meeting, impacting their investment decisions.

Risk Assessment

Risk Level: low — This is a routine filing of additional proxy materials, not indicating any immediate financial or operational risks.

Key Players & Entities

• MASIMO CORP (company) — Registrant
• 0001213900-24-069376.txt (document) — Filing identifier
• 20240815 (date) — Filing date
• DEFA14A (document) — Form type
• 949-297-7000 (phone_number) — Company phone number
• Irvine, CA (location) — Company address

FAQ

Key Financial Figures

• $134 million — pital conversion contracts amounting to $134 million in true incremental value, increasing 2
• $8 — ent to double our earnings per share to $8 in five years. Committed to separatin
• $75 million — t . We generated operating cash flow of $75 million in the second quarter and $120 million
• $120 million — f $75 million in the second quarter and $120 million year-to-date, which allowed us to retir
• $93 million — ear-to-date, which allowed us to retire $93 million from our outstanding debt during the se

Filing Documents

• ea0211507-defa14a_masimo.htm (DEFA14A) — 51KB
• image_001.jpg (GRAPHIC) — 3KB
• 0001213900-24-069376.txt ( ) — 56KB

Forward-Looking Statements

Forward-Looking Statements This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, among others, statements regarding the 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”) of Masimo and the potential stockholder approval of the Board’s nominees and Masimo’s earnings per share estimates and targets; Masimo’s expectations to double earnings within five years; Masimo’s operating margin targets and potential growth; the potential paydown of Masimo’s debt and the expected timing thereof; the proposed separation of Masimo’s consumer business, including any potential joint venture, and the potential timing and structure of any separation and the expectation that the proposed separation will maximize stockholder value or be the best path for success. These forward-looking statements are based on current expectations about future events affecting Masimo and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond Masimo’s control and could cause its actual results to differ materially and adversely from those expressed in its forward-looking statements as a result of various risk factors, including, but not limited to (i) uncertainties regarding future actions that may be taken by Politan in furtherance of its nomination of director candidates for election at the 2024 Annual Meeting, (ii) the potential cost and management distraction attendant to Politan’s nomination of director nominees at the 2024 Annual Meeting and (iii) factors discussed in the “Risk Factors” section of Masimo’s most recent periodic reports filed with the Securities and Exchange Commission (“SEC”), which

View Full Filing

View this DEFA14A filing on SEC EDGAR